PATENT CLAIM ANALYSIS

Application Number: 16061279
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "259410"]

Abstract:
Disclosed in the present invention are a crystalline Form of pyrido[1,2-a]pyrimidone analog, a preparation method therefor and an intermediate thereof,

Claim (Index 24):
Crystalline forms of Compound 1 or the salts thereof of  claim 23 , characterized in that XRPD pattern analysis data of crystalline Form IX is as follows: Relative Nos. 2\u03b8 degree intensity % \u20021 6.014 2.5 \u20022 7.947 29.0 \u20023 10.073 54.2 \u20024 11.970 23.3 \u20025 13.053 5.9 \u20026 13.468 14.4 \u20027 14.531 62.5 \u20028 14.828 49.7 \u20029 15.911 31.1 10 17.369 21.8 11 17.569 26.1 17 17.941 4.5 13 18.377 1.6 14 19.187 55.2 15 19.561 41.3 16 19.855 61.5 17 20.233 22.2 18 21.237 62.8 19 21.984 22.0 20 22.373 3.2 21 23.073 2.2 22 23.446 32.9 23 24.055 100.0 24 24.847 6.6 25 75.497 60.4 26 26.265 1.3 27 27.074 28.0 28 27.448 10.1 29 27.862 22.8 30 28.081 15.6 31 29.005 4.5 32 29.445 3.3 33 30.171 13.0 34 31.014 1.5 35 31.437 0.7 36 31.963 19.5 37 32.381 23.5 38 33.937 9.1 39 34.565 4.7 40 35.218 6.8 41 36.403 5.8 42 36.897 3.7 43 38.103 7.1 44 38.605 6.8 45 39.502 2.6

Metadata:
- Claim Count in Document: 47.0
- Percentile: 94.0
- Lexical Diversity: 1.08333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15504018', '15539147', '16331915', '12559927', '16343165']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8082841350537329
- 35 USC 102 Novelty (BERT): 0.5268445689556744
- Combined Prediction Score: 0.780140178443927
- Mean Citation Score: 323.776176
- Max Citation Score: 338.88705
- Similarity Product: 239.08582599942687

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test